Navigation Links
$36 Billion Charged for Blood Tests and Transfusions for U.S. Premature Infant Market
Date:11/4/2009

th of premature infants,” said Nihat Okulan, PhD, and Chief Technology Officer of NanoStar Health. “Not only do nanotechnology products meet the size needs of these tiny patients, but they also allow us to create new paradigms in clinical methodology including immediate blood test results utilizing significantly smaller sample sizes. For example, nano-sized devices, which are characterized by their high surface to volume ratio, allow for faster response times with the use of lower and safer concentrations of the respective samples," Okulan said.

“Unlike large medical corporations, NanoStar Health is not focused on the larger patient markets. We are a small start-up company hoping to take advantage of stimulus package grants to deliver a product that could reduce the $36 billion dollars in U.S. charges for blood tests and transfusions to less than $2 billion dollars, while still allowing providers to generate reasonable profits for conducting these procedures. We chose not to focus on the largest patient markets, but instead to focus on one of the smallest where we can make the most significant difference for the patients, the economy, and the overall healthcare system,” Chambers said.

“The focus of our medical device development at NanoStar Health is not only assessing the health of premature infants, but doing so in a way that does not further traumatize the premature infant or require a costly healthcare infrastructure. Therefore, these products will not only benefit the infants born in first-world countries like the United States, but in all countries including those where medical technology resources are scarce,” said Black. “Providing healthcare options to underserved patient populations, while simultaneously reducing healthcare costs are the key tenets of our business, nanotechnology is our method of accomplishing this,” Chambers said.

About NanoStar Health™ Corporation


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Naked Juice Brings Consumers Happiness by the Billions With First 100% Juice Smoothie Containing Probiotics
2. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
3. AHCA: Rescinding $2.7 Billion Medicare Cuts Top Issue for Fall Legislative Agenda
4. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
5. Sponsor of Presidential Health Care Forum Has a $4 Billion Conflict of Interest: Kucinich
6. OEM Contract Manufacturing to Grow $11 Billion by 2011
7. New Study Finds Medicaid Under-Funds Long Term Care by $4.4 Billion Annually
8. Billions Directed to Baghdad ... Millions Rejected for Children
9. Billions Directed to Baghdad ... Billions Rejected for Children
10. U.S. Invests $9.3 Billion in Research to Improve Health Globally
11. New Report Estimates Cost of Low Health Literacy Between $106 - $236 Billion Annually

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
$36 Billion Charged for Blood Tests and Transfusions for U.S. Premature Infant Market 
$36 Billion Charged for Blood Tests and Transfusions for U.S. Premature Infant Market
(Date:11/27/2009)...v. 27 The Gymboree Corpo...rt, CFO/COO, will present at the NASDAQ OMX 23rd I...r Hotel in London, England, on Wednesday, December...live broadcast of The Gymboree Corporation,s prese...mboree.com, click on "Our Company" at the bottom o...
(Date:11/27/2009)...naCare Holdings has announced that it has become a... of the largest nonprofit organizations dedicated ... , Delray Beach, FL (Vocu...TCBB: XCHO), a company specializing in the marketi...products, has announced today that is has become a...
(Date:11/27/2009)...yant Health™ announced today that Spectrum H...aumaCad Enterprise orthopedic templating solution ... (PRWEB) November 27, 2009 -- ... Health (Grand Rapids, Michigan) has licensed its ...n and its TraumaCad Extend workflow solution, to a...
(Date:11/26/2009)...7 With cold and flu season upon us...ctices to control the spread of infections and avo...y to keep ourselves healthy, but to avoid transmit...RN, MS, CIC (certified in infection-control), nurs...l health at Hospital for Special Surgery (HSS) in ...
(Date:11/26/2009)...o heavy can lead to strains or worse , ,...e nothing wrong with stuffing your turkey full to ...ing with your suitcase as you pack for holiday tri...008 in U.S. hospital emergency rooms, doctors, off...gage-related injuries, such as muscle strains, pul...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2
...World Health Day' is celebrated on the 7 th of...rks the founding of the World Health Organization....zero in on key health-related issues and to raise ...sectors and other non- governmental organizations ...
...ourth Annual Neurosurgery Awareness Week (NAW) kic...Annual Meeting of the American Association// of Ne...roximately 3,000 neurosurgical medical professiona...heral nerves, pediatrics, stereotactic, trauma, an...
...resident, Dr Mukesh Haikerwal, has written to the ...g the Council of Australian Governments// (COAG) t...ained in recognizing and handling anaphylactic rea...ergic reactions. 'Greater awareness and man...
...ntroduction of new standards to assess nutrition i...e numbers of malnourished children eligible// for ...is week’s BMJ. According to the UN World Foo... per year since 2000. In 2005, around 73 million p...
...eers of Johns Hopkins claims to have invented a mo...to perform cancer biopsies and therapies guided// ...at drives the devices can be so precisely controll...rformed blind because the tumors are typically inv...
...atment developed by a pediatric orthopedic surgeon...formity in children. The treatment for rigid flatf...now be corrected with minimal surgery. Cong...de of the ankle rather than the bottom of the foot...
Other Medicine News:Health News:'Invest in Health, Build a Safer Future': World Health Day 2Health News:National Neurosurgery Awareness Week Kicks Off During Annual Meeting of the AANS 2Health News:COAG Must Make Combating Severe Allergies A National Priority 2Health News:New Standards Could Cut Number of Malnourished Children on Feeding Programs 2Health News:MRI-safe Motor Makes Robotic Biopsies Possible 2Health News:Foot Deformity Could Be Corrected With Minimal Surgery 2
(Date:11/25/2009)...PRNewswire/ -- According to Millennium Research Gr...ogy market intelligence, the nearly $3 billion US ...o see rapid growth over the next five years despit...for Trauma Devices 2010 report finds that this ...ve years, with competitors introducing specialized...
(Date:11/25/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Pain Management - Global Trends ,, ...nt---Global-Trends.html ,, Widespread availabi...t clinics, and the advent of new drugs have accele...rket. Healthcare reforms and reimbursement structu...
(Date:11/25/2009)... Nov. 25 HeartWare Inter...ng innovator and provider of less invasive, miniat...izing the treatment of advanced heart failure, tod...tor presentation at the 21st Annual Piper Jaffray ..., December 2, 2009. The conference is being held a...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Study Casts Doubt on Low IQs Role in Early Death 50630 1Study Casts Doubt on Low IQs Role in Early Death 50630 2Connectyx Technologies Holdings Group Inc Signs an Agreement with Healthy Directions LLC Americas Largest Publisher of Alternative and Complementa 50627 1Connectyx Technologies Holdings Group Inc Signs an Agreement with Healthy Directions LLC Americas Largest Publisher of Alternative and Complementa 50627 2Is Financial Infidelity a Threat to Your Marriage 3F Psychiatrist Says It Can Be More Devastating Than an Affair 50624 1Is Financial Infidelity a Threat to Your Marriage 3F Psychiatrist Says It Can Be More Devastating Than an Affair 50624 2
...)--May 2, 2007 - Acorda Therapeutics, Inc.(R),(Nas...nical trial,of Fampridine-SR in people with multip...logy meeting. Andrew Goodman, M.D.,Director of th...ochester, presented top-line results on walking ab...subject global impressions.,Dr. Goodman also prese...
...sitive Data in Nonclinical (IND) In- Vitro,Studies... 2007 (PRIME NEWSWIRE) -- Samaritan,Pharmaceutical...,is pleased to announce positive results were att...testing of Caprospinol (SP-233),with well recogni...ch results are imperfect predictors,of clinical re...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 2Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro,Studies for Promising Alzheimer's Drug 3
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-340
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-330A
Single Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-320
Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters with Lumen; SPC-784A
Medicine Products: